Assessment of 2022 European LeukemiaNet risk classification system in real‐world cohort from China

Assessment of 2022 European LeukemiaNet risk classification system in real‐world cohort from China

Abstract Background The European LeukemiaNet (ELN) risk classification system for acute myeloid leukemia (AML) patients has been used worldwide. In 2022, the ELN risk classification system modified risk genes including CEBPA mutation status, myelodysplasia‐related (MR) gene mutations and internal ta...

Celý popis

Podrobná bibliografie
Hlavní autoři: Enbo Chen, Changqing Jiao, Jian Yu, Yu Gong, Duo Jin, Xiaoyu Ma, Jianling Cui, Zhonghui Wu, Junjie Zhou, Haixia Wang, Bobing Su, Jian Ge
Médium: Článek
Jazyk:English
Vydáno: Wiley 2023-12-01
Edice:Cancer Medicine
Témata:
acute myeloid leukemia
European LeukemiaNet
FLT3‐ITD mutations
real‐world
risk classifications
On-line přístup:https://doi.org/10.1002/cam4.6696

Internet

https://doi.org/10.1002/cam4.6696

Podobné jednotky